SCHEMBL16727

SCHEMBL16727

O=S(=O)(c1cccs1)N1CCN(c2ccc(C(O)(CF)C(F)F)cc2)[C@@H](CNC2COC2)C1

nearest known ligand 0.56

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GCK P35557 8/20 0.56
GCKR Q14397 12/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17667 0.92 GCKR (0.61) GCKGCKR
SCHEMBL15200827 0.87 GCKR (0.60) GCKGCKR
SCHEMBL12089781 0.87 GCK (0.62) GCKGCKR
SCHEMBL19706 0.86 GCK (0.73) GCKGCKR
SCHEMBL16390 0.86 GCK (0.73) GCKGCKR
SCHEMBL12078599 0.86 GCK (0.73) GCKGCKR
SCHEMBL16197 0.86 GCKR (0.62) GCKGCKR
SCHEMBL16425 0.86 GCKR (0.62) GCKGCKR
SCHEMBL17456 0.84 GCKR (0.63) GCKGCKR
SCHEMBL15200930 0.84 GCK (0.55) GCKGCKR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2609081-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES Amgen Inc. (US) 2013-07-03 EP disclosed
WO-2012027261-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES AMGEN INC. (US) 2012-03-01 WO disclosed